These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28842394)

  • 1. Transforming Growth Factor-
    Ungefroren H; Witte D; Mihara K; Rauch BH; Henklein P; Jöhren O; Bonni S; Settmacher U; Lehnert H; Hollenberg MD; Kaufmann R; Gieseler F
    Mol Pharmacol; 2017 Nov; 92(5):519-532. PubMed ID: 28842394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.
    Zeeh F; Witte D; Gädeken T; Rauch BH; Grage-Griebenow E; Leinung N; Fromm SJ; Stölting S; Mihara K; Kaufmann R; Settmacher U; Lehnert H; Hollenberg MD; Ungefroren H
    Oncotarget; 2016 Jul; 7(27):41095-41109. PubMed ID: 27248167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility.
    Ungefroren H; Witte D; Fiedler C; Gädeken T; Kaufmann R; Lehnert H; Gieseler F; Rauch BH
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29261154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1.
    Ungefroren H; Groth S; Sebens S; Lehnert H; Gieseler F; Fändrich F
    Mol Cancer; 2011 May; 10():67. PubMed ID: 21624123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling.
    Ungefroren H; Witte D; Rauch BH; Settmacher U; Lehnert H; Gieseler F; Kaufmann R
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action.
    Bartscht T; Rosien B; Rades D; Kaufmann R; Biersack H; Lehnert H; Gieseler F; Ungefroren H
    Mol Cancer; 2015 Nov; 14():199. PubMed ID: 26588899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β1 induces proteinase-activated receptor 2 (PAR2) expression in endometriotic stromal cells and stimulates PAR2 activation-induced secretion of IL-6.
    Saito A; Osuga Y; Yoshino O; Takamura M; Hirata T; Hirota Y; Koga K; Harada M; Takemura Y; Yano T; Taketani Y
    Hum Reprod; 2011 Jul; 26(7):1892-8. PubMed ID: 21546388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus.
    Olieslagers S; Pardali E; Tchaikovski V; ten Dijke P; Waltenberger J
    Cardiovasc Res; 2011 Aug; 91(3):510-8. PubMed ID: 21478266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
    Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
    Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
    Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta1 downregulates caveolin-1 expression and enhances sphingosine 1-phosphate signaling in cultured vascular endothelial cells.
    Igarashi J; Shoji K; Hashimoto T; Moriue T; Yoneda K; Takamura T; Yamashita T; Kubota Y; Kosaka H
    Am J Physiol Cell Physiol; 2009 Nov; 297(5):C1263-74. PubMed ID: 19710365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA; Kang MH; Kim JS; Oh SC
    Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAC1B Suppresses TGF-β-Dependent Chemokinesis and Growth Inhibition through an Autoregulatory Feed-Forward Loop Involving PAR2 and ALK5.
    Otterbein H; Mihara K; Hollenberg MD; Lehnert H; Witte D; Ungefroren H
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31434318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-β1 up-regulates connexin43 expression in human granulosa cells.
    Chen YC; Chang HM; Cheng JC; Tsai HD; Wu CH; Leung PC
    Hum Reprod; 2015 Sep; 30(9):2190-201. PubMed ID: 26202915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor.
    Park SJ; Choi YS; Lee S; Lee YJ; Hong S; Han S; Kim BC
    Cancer Lett; 2016 Oct; 381(2):314-22. PubMed ID: 27543359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization.
    Hwangbo C; Tae N; Lee S; Kim O; Park OK; Kim J; Kwon SH; Lee JH
    Oncogene; 2016 Jan; 35(3):389-401. PubMed ID: 25893292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells.
    Dumont N; Bakin AV; Arteaga CL
    J Biol Chem; 2003 Jan; 278(5):3275-85. PubMed ID: 12421823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
    Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
    Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rac1b negatively regulates TGF-β1-induced cell motility in pancreatic ductal epithelial cells by suppressing Smad signalling.
    Ungefroren H; Sebens S; Giehl K; Helm O; Groth S; Fändrich F; Röcken C; Sipos B; Lehnert H; Gieseler F
    Oncotarget; 2014 Jan; 5(1):277-90. PubMed ID: 24378395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.